Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2020

Every FDA drug recall initiated in 2020, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

930 recalls, newest first.

Class III · Low risk

Famotidine Injection

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Terminated Temperature excursion HF Acquisition Co. LLC NDC 63323-739-12 D-1392-2020
Class II · Moderate risk

Childrens Dimetapp Cold & Cough

Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.

Terminated Packaging defect Glaxosmithkline Consumer Healthcare Holdings D-1362-2020
Class II · Moderate risk

Heparin Sodium 5

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

Terminated Wrong potency / content SCA Pharmaceuticals NDC 70004-0650-46 D-1311-2020
Class II · Moderate risk

Tropical Lip Moisturizer

Superpotent Drug: The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate.

Terminated Wrong potency / content Yusef Manufacturing Laboratories, LLC D-1486-2020
Class II · Moderate risk

Clozapine Tablets USP tablet

Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.

Terminated Particulate / foreign matter Aurobindo Pharma USA Inc. NDC 65862-846-05 D-1370-2020
Class II · Moderate risk

Koala Hand Sanitizer

Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Terminated Wrong potency / content Beaming White Llc D-1359-2020
Class II · Moderate risk

Koala Hand Sanitizer

Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Terminated Wrong potency / content Beaming White Llc D-1358-2020
Class II · Moderate risk

Koala Hand Sanitizer

Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Terminated Wrong potency / content Beaming White Llc D-1357-2020
Class II · Moderate risk

Irinotecan HCL Injection

Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.

Terminated Packaging defect Hikma Pharmaceuticals USA Inc. NDC 0143-9583-01 D-1309-2020
Class II · Moderate risk

Irinotecan HCL Injection

Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.

Terminated Packaging defect Hikma Pharmaceuticals USA Inc. NDC 0143-9701-01 D-1308-2020
Class III · Low risk

Nabumetone Tablets

Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.

Terminated Labeling / mix-up American Health Packaging D-1372-2020
Class II · Moderate risk

Aripiprazole Tablets

Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.

Terminated Labeling / mix-up Alembic Pharmaceuticals Limited NDC 62332-097-30 D-1341-2020
Class II · Moderate risk

Nystatin Cream

Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.

Terminated Wrong potency / content Crown Laboratories NDC 0316-0221-15 D-1339-2020
Class II · Moderate risk

Nystatin Cream

Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.

Terminated Wrong potency / content Crown Laboratories NDC 0316-0221-30 D-1338-2020

Recalls by year